APM
ANRO icon

Avidity Partners Management’s Alto Neuroscience ANRO Stock Holding History

Avidity Partners Management’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-240,000
Closed -$2.75M – 85
2024
Q3 		$2.75M Buy
+240,000
New +$2.94M 0.14% 72

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Avidity Partners Management's ANRO Position: Q4 2024 in Review

Avidity Partners Management sold out of Alto Neuroscience (ANRO) in Q4 2024, closing a stake of 240,000 shares — an estimated $2.75M sold.

Avidity Partners Management first reported a position in ANRO in Q3 2024 and held it in 1 quarter. The position peaked at $2.75M in Q3 2024. 77 funds tracked by Wall St. Rank hold ANRO as of Q4 2024.

  • Avidity Partners Management reported no remaining Alto Neuroscience position as of Q4 2024 after selling out during the quarter.
  • Avidity Partners Management sold 240,000 Alto Neuroscience shares in Q4 2024, an estimated $2.75M.
  • Avidity Partners Management first reported a position in Alto Neuroscience in Q3 2024 and held it in 1 quarter.
  • Avidity Partners Management's Alto Neuroscience position peaked at $2.75M in Q3 2024.
  • 77 funds tracked by Wall St. Rank held Alto Neuroscience as of Q4 2024.

Based on Avidity Partners Management's 13F filing for Q4 2024, filed 14 Feb 2025.